These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 33191360)

  • 1. Comparison of Procedural and 1-Year Clinical Results of Transcatheter Aortic Valve Implantation Using Prostheses with Different Design of Support Frame.
    Li F; Wang X; Wang Y; Li X; Xu D; Zhao S; Wang C; Guo Y; Wu Y; Wang W
    Int Heart J; 2020 Nov; 61(6):1196-1203. PubMed ID: 33191360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short term clinical outcomes and analysis of risk factors for pacemaker implantation: a single center experience of self-expandable TAVI valves.
    Chow SCY; Wong RHL; Cheung GSH; Lee APW; Chui HKL; So KCY; Wu EB
    J Cardiothorac Surg; 2020 Jul; 15(1):200. PubMed ID: 32727521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term pacemaker dependency after transcatheter aortic valve implantation.
    Schernthaner C; Kraus J; Danmayr F; Hammerer M; Schneider J; Hoppe UC; Strohmer B
    Wien Klin Wochenschr; 2016 Mar; 128(5-6):198-203. PubMed ID: 26745972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conduction recovery and avoidance of permanent pacing after transcatheter aortic valve implantation.
    Marzahn C; Koban C; Seifert M; Isotani A; Neuß M; Hölschermann F; Butter C
    J Cardiol; 2018 Jan; 71(1):101-108. PubMed ID: 28818562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early versus newer generation transcatheter heart valves for transcatheter aortic valve implantation: Echocardiographic and hemodynamic evaluation of an all-comers study cohort using the dimensionless aortic regurgitation index (AR-index).
    Stundl A; Lucht H; Shamekhi J; Weber M; Sedaghat A; Mellert F; Grube E; Nickenig G; Werner N; Sinning JM
    PLoS One; 2019; 14(5):e0217544. PubMed ID: 31150455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of tricuspid regurgitation and new pacemaker implantation in patients undergoing transcatheter aortic valve implantation.
    Schewel D; Schewel J; Schlüter M; Kreidel F; Schmidt T; Schmoeckel M; Elsässer A; Kuck KH; Frerker C
    Int J Cardiol; 2018 Jun; 261():37-41. PubMed ID: 29572082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transaortic transcatheter aortic valve implantation: Results of the Polish arm of the ROUTE registry.
    Jagielak D; Bramlage P; Pawlaczyk R; Brzeziński M; Fijałkowski M; Łaskawski G; Ciećwierz D; Rogowski J; Kozaryn R
    Cardiol J; 2015; 22(6):651-6. PubMed ID: 26202653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic comparison of CoreValve and SAPIEN-XT TAVI valves in Japanese patients.
    Shishido K; Yamanaka F; Ochiai T; Yamabe T; Noguchi K; Ota T; Koide Y; Ogino H; Tanaka Y; Saito S
    Heart Vessels; 2019 Oct; 34(10):1674-1683. PubMed ID: 30993441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of three different new generation transcatheter aortic valve prostheses.
    Costa G; Buccheri S; Barbanti M; Picci A; Todaro D; Di Simone E; La Spina K; D'Arrigo P; Criscione E; Nastasi M; Sgroi C; Tamburino C
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):398-407. PubMed ID: 31609073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Need for pacemaker implantation in patients with normal QRS duration immediately after transcatheter aortic valve implantation.
    Schoechlin S; Jalil F; Blum T; Ruile P; Hein M; Nührenberg TG; Arentz T; Neumann FJ
    Europace; 2019 Dec; 21(12):1851-1856. PubMed ID: 31578544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-Analysis of Transcatheter Aortic Valve Implantation in Patients With Stenotic Bicuspid Versus Tricuspid Aortic Valve.
    Majmundar M; Kumar A; Doshi R; Shah P; Arora S; Shariff M; Adalja D; Visco F; Amin H; Vallabhajosyula S; Gullapalli N; Kapadia SR; Kalra A; Panaich SS
    Am J Cardiol; 2021 Apr; 145():102-110. PubMed ID: 33460604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, indications and predicting factors of permanent pacemaker implantation after transcatheter aortic valve implantation: A retrospective study.
    Becker M; Blangy H; Folliguet T; Villemin T; Freysz L; Luc A; Maureira P; Popovic B; Olivier A; Sadoul N
    Arch Cardiovasc Dis; 2017 Oct; 110(10):508-516. PubMed ID: 28647466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter Heart Valve Selection and Permanent Pacemaker Implantation in Patients With Pre-Existent Right Bundle Branch Block.
    van Gils L; Tchetche D; Lhermusier T; Abawi M; Dumonteil N; Rodriguez Olivares R; Molina-Martin de Nicolas J; Stella PR; Carrié D; De Jaegere PP; Van Mieghem NM
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28258051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procedural Outcome and Midterm Survival of Lower Risk Transfemoral Transcatheter Aortic Valve Implantation Patients Treated With the SAPIEN XT or SAPIEN 3 Device.
    Vendrik J; van Kesteren F; van Mourik MS; Piek JJ; Tijssen JG; Henriques JPS; Wykrzykowska JJ; de Winter RJ; Driessen AHG; Kaya A; Vis MM; Koch KT; Baan J
    Am J Cardiol; 2018 Apr; 121(7):856-861. PubMed ID: 29415808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve.
    Gonska B; Seeger J; Keßler M; von Keil A; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2017 Aug; 106(8):590-597. PubMed ID: 28283746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review.
    van Rosendael PJ; Delgado V; Bax JJ
    Eur Heart J; 2018 Jun; 39(21):2003-2013. PubMed ID: 29420704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender Disparities in Management and Outcomes Following Transcatheter Aortic Valve Implantation With Newer Generation Transcatheter Valves.
    Wang TY; Gracia E; Callahan S; Bilfinger T; Tannous H; Pyo R; Kort S; Skopicki H; Weinstein J; Patel N; Montellese D; Korlipara G; Khan S; Chikwe J; Parikh PB
    Am J Cardiol; 2019 May; 123(9):1489-1493. PubMed ID: 30782416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-Year Follow-Up of Conduction Abnormalities After Transcatheter Aortic Valve Implantation With the SAPIEN 3 Valve.
    Dolci G; Vollema EM; van der Kley F; de Weger A; Ajmone Marsan N; Delgado V; Bax JJ
    Am J Cardiol; 2019 Oct; 124(8):1239-1245. PubMed ID: 31439281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.
    Kedev S; Zafirovska B; Srbinovska-Kostovska E; Antov S; Nikolic A; Dzemali O; Bunc M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):5-14. PubMed ID: 31605589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.